Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Pharmaceuticals Top Trending Markets - By The Business Research Company

This image opens in the lightbox

News provided by

The Business Research Company

11 Sep, 2023, 10:07 GMT

Share this article

Share toX

Share this article

Share toX

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

LONDON, Sept. 11, 2023 /PRNewswire/ -- As per The Business Research Company's analysis, the pharmaceuticals market is poised for substantial growth in the coming years, with projections indicating a remarkable trajectory. It is anticipated that the market will surge to $2,050 billion by 2025 and further escalate to a staggering $3,206 billion by the year 2030. This dynamic expansion is attributed to various factors, including advancements in healthcare technologies, increasing global healthcare expenditures, and the growing prevalence of chronic diseases, all of which drive demand for pharmaceutical products and services.

tbrc Logo

In this thriving pharmaceutical landscape, business intelligence and market insights play a pivotal role in guiding companies towards informed decision-making. Reports from The Business Research Company (TBRC) offer invaluable assistance to businesses within the pharmaceuticals industry. These reports provide comprehensive analyses of market trends, competitive landscapes, and emerging opportunities, allowing pharmaceutical companies to stay ahead of the curve.

By leveraging TBRC's reports, businesses can strategize effectively, identify untapped markets, and make well-informed investments, ensuring they remain competitive and successful in this rapidly evolving sector.

Explore The Business Research Company's top eleven market reports in the pharmaceuticals industry:

1.  Antibody Drug Conjugates Global Market Report 2023       
https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report

The global antibody drug conjugates market is projected to expand from $16.15 billion in 2027, with a compound annual growth rate (CAGR) of 22.4%. This growth is fueled by the increasing prevalence of cancer on a worldwide scale.

2.  Erythropoietin (EPO) Global Market Report 2023                               https://www.thebusinessresearchcompany.com/report/erythropoietins-global-market-report

The erythropoietin market is forecasted to experience a growth in market size, rising from $24.2 billion in 2027, with a CAGR of 11.7%. This expected expansion in the erythropoietin market is attributed to the increasing prevalence of chronic kidney diseases, which is expected to drive demand in the years ahead.

3.  G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2023                          https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

The global gastrointestinal devices market is projected to expand from $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 6.6%. This growth can be attributed to the rising incidence of gastrointestinal diseases, which has played a significant role in driving the demand for gastrointestinal devices.

4.  HP (High Potency) APIs Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/hp-high-potency-api-global-market-report

The global market for high potency APIs (Active Pharmaceutical Ingredients) is anticipated to increase from $36.14 billion in 2027, with a compounded annual growth rate (CAGR) of 7.9%. This growth is fueled by the growing incidence of cancer cases and the rising sales of cancer drugs, which have played a pivotal role in driving the high potency APIs market.

5.  Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2023                https://www.thebusinessresearchcompany.com/report/vascular-endothelial-growth-factor-inhibitors-global-market-report

The market size for vascular endothelial growth factor (VEGF) inhibitors is projected to increase from $12.11 billion in 2027, with a compound annual growth rate (CAGR) of 7.8%. This growth is primarily attributed to the rising prevalence of cancer and macular degeneration diseases, which are expected to be the key drivers of the VEGF inhibitor market.

6.  Anesthetics Global Market Report 2023                
https://www.thebusinessresearchcompany.com/report/anesthetics-global-market-report

An emerging trend in the anesthetics market is the growing consolidation through acquisitions. This trend is primarily driven by the substantial investments required for research and development (R&D) as well as intellectual property (IP) development to establish companies engaged in the production of anesthetic drugs. Consequently, mergers and acquisitions are being recognized as efficient and cost-effective approaches in this regard.

7.  Antacids Global Market Report 2023                      
https://www.thebusinessresearchcompany.com/report/antacids-global-market-report

An emerging trend in the antacid market is the introduction of mouth-melting antacids. While antacids were traditionally available in tablet, liquid, and powder forms, researchers have now developed mouth-melting antacids composed of micro-granules that rapidly dissolve in the mouth. These granules within the antacids function in an effervescent manner, providing consumers with a convenient and quick-dissolving option for relief from acidity and heartburn.

8.  Antiemetics And Antinauseants Global Market Report 2023                          https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Manufacturers in the antiemetics and antinauseants market are leveraging nanotechnology to administer therapeutic agents with precision to specific sites in a controlled manner, employing nanomedicine and nano delivery systems. There is a growing inclination among antiemetic and antinauseant drug manufacturers to utilize nanomedicine or nano drugs to enhance the effectiveness of their medications and boost their revenue streams.

9.  Anti-Thyroid Drugs Global Market Report 2023                  
https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

The global market for anti-thyroid drugs market is projected to reach $2.78 billion by 2027, with a compound annual growth rate (CAGR) of 2.5%. One of the primary factors contributing to this growth is the rising incidence of Graves' disease, a direct cause of hyperthyroidism.

10.  Antivirals Global Market Report 2023                     
https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Companies operating in the anti-viral drug therapy market are consistently driving innovation through technological advancements to create treatments for various viral infections. Biopharmaceutical firms are actively engaged in the development of vaccines for combating novel coronaviruses. Notable technological progress in the pharmaceutical sector encompasses the formulation of nucleic acid vaccines that utilize DNA and RNA-based platforms, allowing the human body to generate vaccine antigens.

11.  Bladder Cancer Drugs Global Market Report 2023                              https://www.thebusinessresearchcompany.com/report/bladder-cancer-drugs-global-market-report

Prominent entities within the bladder cancer drugs market are channeling significant investments into research focused on harnessing nano-technology for drug delivery into the human body. This approach holds the promise of providing healthcare professionals with a straightforward and efficient means of treating bladder cancer in patients. By utilizing nanoparticles in treatment, doctors can directly target cancerous cells while minimizing damage to surrounding healthy cells, enhancing the overall effectiveness and precision of bladder cancer treatment.

Interested to know more about The Business Research Company?

The Business Research Company has published over 6500+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact Information

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Logo - https://mma.prnewswire.com/media/1751581/tbrc_logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.